Call Us: 888-488-2702

Amgen to pay $762 million in misbranding case

By on Dec 18, 2012 in News |

Amgen, the world’s largest biotechnology firm, pleaded guilty in federal court in New York to criminal charges that it illegally misbranded its anemia drug Aranesp and agreed to pay $762 million.